The antiviral drug arabinosyladenine inhibited cellular growth and DNA synthesis in an adenosine deaminase-negative cell line (B-mix K-44/6). Use of adenosine deaminase-containing calf serum in the culture medium reversed the drug-induced inhibition and resulted in a recovery of both mitosis and the rate of DNA synthesis.
Get full access to this article
View all access options for this article.
References
1.
Conen, S.S.: Introduction to the Biochemistry of D-Arabinosyl Nucleosides, Prog Nucl Acid Res Mol Biol5:1-88, 1966.
2.
Lepage, G.A.: Alterations in Enzyme Activity in Tumors and the Implications for Chemotherapy , Advan Enzyme Regul8: 323-332, 1970.
3.
Suhadolnik, R.J. : Nucleoside Antibiotics, New York: Wiley-Interscience, 1970, pp. 123-159.
4.
Schabel, F.M., JR.: The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (Ara-A) , Chemotherapy13:321-338, 1968.
5.
Shannon, W.M.: Adenine Arabinoside: Antiviral Activity In Vitro, in Pavan-Langston, D.; Buchanan, R.A.; and Alford, C.A., Jr. (eds) : Adenine Arabinoside : An Antiviral Agent, New York: Raven Press, 1975, pp 1-43.
6.
Sloan, B.J. : Adenine Arabinoside: Chemotherapy Studies in Animals, in Pavan-Langston, D.; Buchanan, R.A.; and Alford, C.A., Jr. (eds) : Adenine Arabinoside: An Antiviral Agent, New York: Raven Press, 1975, pp. 45-94.
7.
Pavan-Langston, D.; Buchanan, R.A.; and Alford, C.A., Jr. (eds) : Ophthalmic Studies, in Adenine Arabinoside: An Antiviral Agent , New York: Raven Press, 1975, pp 293-416.
8.
Whitley, R.J.; Ch'Ien, L.T.; Dolin, R.; GALASso, G.J.; and Alford, C.A., Jr. (eds) : Adenine Arabinoside Therapy of Herpes Zoster in the Immunosuppressed, N Engl J Med294:1193-1199, 1976.
9.
Kurtz, S.M.: Toxicology of Adenine Arabinoside, in Pavan-Langston, D.; Buchanan, R.A.; and Alford, C.A., Jr. (eds) : Adenine Arabinoside: An Antiviral Agent, New York: Raven Press, 1975, pp 145-157.
10.
Ch'ien, L.T.; Whitley, R.J. ; Nahmias, A.J. ; Lewin, E.B.; Linnemann, C.C.; Frenkel, L.D.; Bellanti, J.A. ; Buchanan, R.A.; and Alford, C.A., JR.: Antiviral Chemotherapy and Neonatal Herpes Simplex Virus Infection: A Pilot Study-Experience with Adenine Arabinoside (Ara-A), Pediatrics65:678-685, 1975.
11.
Aronson, M.D. ; Phillips, C.F.; Gump , D.W.; Albertini, R.J.; and Phillips , C.A.: Vidarabine Therapy for Severe Herpesvirus Infection, J Am Med Assn235:1339-1342, 1976.
12.
Shipman, C. JR. ; Smith, S.H.; Carlson , R.H.; and Drach, J.C.: Antiviral Activity of Arabinosyladenine and Arabinosylhypoxanthine in Herpes Simplex Virus-Infected KB Cells. I. Selective Inhibition of Viral DNA Synthesis in Synchronized Suspension Cultures, Antimicrob Agents Chemother9: 120-127, 1976.
13.
Schwartz, P.M.; Shipman, C., JR. ; and Drach, J.C.: Antiviral Activity of Arabino. syladenine and Arabinosylhypoxanthine in Herpes Simplex Virus-Infected KB Cells. II. Selective Inhibition of Viral DNA Synthe
14.
sis in the Presence of an Adenosine Deaminase Inhibitor, Antimicrob Agents Chemother10:64-74, 1976.
15.
Drach, J.C. , and Shipman, C., JR. : The Selective Inhibition of Viral DNA Synthesis by Chemotherapeutic Agents: An Indicator of Clinical Usefulness?Ann NY Acad Sci In press.
16.
Brink, J.J. , and Lepage, G.A.: Metabolic Effects of 9-D-Arabinosylpurines in Ascites Tumor Cells, Cancer Res24:312-318, 1964.
17.
Doering, A. ; Keller, J.; and Cohen, S.S.: Some Effects of D-Arabinosyl Nucleosides on Polymer Synthesis in Mouse Fibroblasts, Cancer Res26:2444-2450, 1966 .
18.
Lepage, G.A. : Manipulation of DNA Synthesis in Normal and Neoplastic Tissue with Drugs, Advan Enzyme Regul12:373-381, 1974.
19.
Lepage, G.A. ; Worth, L.S.; and Kimball, A.P.: Enhancement of the Antitumor Activity of Arabinofuranosyladenine by 2'-Deoxycoformycin , Cancer Res36 :1481-1485, 1976 .
20.
Woo, P.W.K. ; Dion, H.W.; Lange , S.M.; Dahl, L.F.; and Durham, L.J.: A Novel Adenosine and Ara-A Deaminase Inhibitor, (R)-3- (2-Deoxy-β-D-Erythropentofuranosyl)-3,6,7,8-tetrahydroimidazo [4,5-d] [1,3] Diazepin-8-ol, J Heterocycl Chem11:641-643, 1974.
21.
Nakamura, H. ; Koyama, G. ; Iitaka , Y.; Ohno, M.; Yagisawa, N.; Kondo, S.: Maeda, K.; and Umezawa, H.: Structure of Coformycin, an Unusual Nucleoside of Microbial Origin, J Am Chem Soc96 :4327-4328, 1974.
22.
Schaeffer, H.J., and Schwender , C.F.: Enzyme Inhibitors. 26. Bridging Hydrophobic and Hydrophilic Regions on Adenosine Deaminase with Some 9-(2-Hydroxy-3-Alkyl) Adenines, J Med Chem17:6-8, 1974.
23.
Plunkett, W. , and Cohen, S.S.: Two Approaches that Increase the Activity of Analogs of Adenine Nucleosides in Animal Cells, Cancer Res35:1547-1554, 1975.
24.
Cass, C.E., and Au-Yeung, T.H. : Enhancement of 9-β-D-Arabinofuranosyladenine Cytotoxicity to Mouse Leukemia L1210 In Vitro by 2'-Deoxycoformycin, Cancer Res36:1486-1491, 1976 .
25.
Svoboda, J. ; Vesely, P.; and Donner, L.: Characteristics of Highly Polyploid Clones Isolated from Lines of RSV-Transformed Rat Cells , Folia Biol (Praha)13:40-43, 1976.
26.
Shipman, C. , JR. ; Novack, J.M. ; and Drach, J.C.: Effect of 9-β-D-Arabinofuranosyladenine (Ara-A) and 9-β-D-Arabinofuranosylhypoxanthine (Ara-Hx) on Growth Rate and Nucleic Acid Synthesis in B-Mix K44/6 Cells, Fed Proc32:699, 1973.
27.
Shipman, C., JR.; Sandberg, J.N.; Schwartz, P.M.; and Drach, J.C.: An Established Mammalian Cell Line Devoid of Adenosine Deaminase Activity: B-Mix K-44/6, 15th Interscience Conf Antimicrob Agents Chemother: Abstract No. 358, 1975.
28.
Ishii, K., and Green, H.: Lethality of Adenosine for Cultured Mammalian Cells by Interference with Pyrimidine Biosynthesis, J Cell Sci13:429-439, 1973.
29.
Ortiz, P.J. ; Manduka, M.J. ; and Cohen, S.S.: The Lethality of Some D-Arabinosyl Nucleotides to Mouse Fibroblasts , Cancer Res32:1512-1517, 1972 .
30.
Schwartz, P.M. ; Shipman, C., JR.; Carlson, R.H.; and Drach, J.C.: Thermal Inactivation as a Means of Inhibiting the Serum-Associated Deamination of 9-β-D-Arabinofuranosyladenine in Tissue Culture Media, Antimierob Agents Chemother5: 337-343, 1974.
31.
Shipman, C. , JR.: Evaluation of 4-(2-Hydroxyethyl)-1-piperazineëthanesulfonic Acid (HEPES) as a Tissue Culture Buffer, Proc Soc Exp Biol Med140:305-310, 1968.
32.
Hayflick, L.: Screening Tissue Cultures for Mycoplasma Infections, in Kruse, P.F., Jr., and Patterson, M.K., Jr. (eds) ; Tissue Culture: Methods and Applications , New York: Academic Press, 1973, pp 722-728.
33.
Bacnara, A.S. , and Finch, L.R.: Quantitative Extraction and Estimation of Intracellular Nucleoside Triphosphates of Escherichia coli, Anal Biochem45:24-34, 1972.
34.
Giles, K.W. , and Myers, A.: An Improved Diphenylamine Method for the Estimation of Deoxyribonucleic Acid, Nature206:93, 1965.
35.
Randerath, K., and Randerath, E.: IonExchange Chromatography of Nucleotides on Poly-(ethyleneiminc)-Cellulose Thin Layers, J Chromatogr16:111-125, 1964.
36.
Miller, F.A. ; Dixon, G.J.; Ehrlich , J.; Sloan, B.J.; and McLean , I.W., JR.: Antiviral Activity of 9-β-D-Arabinofuranosyladenine . I. Cell Culture Studies, Antimicrob Agents Chemother1968:136-147, 1969.
37.
Shannon, W.M. ; Westbrook, L.; and Schabel, F.M., JR.: Antiviral Activity of 9-β-D-Arabinofuranosyladenine (Ara-A) Against Gross Murine Leukemia Virus in Vitro, Proc Soc Exp Biol Med145:542-545, 1974.
38.
Leung, H.B. ; Doering, A.M.; and Cohen, S.S.: Effect of 9-β-D-Arabinofuranosyladenine on Polymer Synthesis in a Polyauxotrophic Strain of Escherichia coli, J Bacteriol92:558-564, 1966.
39.
Chou, T.-C. ; Hutchison, D.J.; Schmid , F.A.; and Phillips , F.S.: Metabolism and Selective Effects of 1-β-D-Arabinofuranosylcytosine in L1210 and Host Tissue in Vivo, Cancer Res35:225-236, 1975.
40.
Roberts, D. , and Loehr, E.V.: Depression of Thymidylate Synthetase Activity in Response to Cytosine Arabinoside, Cancer Res32:1160-1169, 1972.
41.
Grindey, G.B. , and Nichol, C.A.: Interaction of Drugs Inhibiting Different Steps in the Synthesis of DNA, Cancer Res32 :527-531, 1972.
42.
Brink, J.J. , and Lepage, G.A.: 9-β-D-Arabinofuranosyladenine as an Inhibitor of Metabolism in Normal and Neoplastic Cells, Can J Biochem43:1-15, 1965.
43.
Hughes, R.G. , JR., and Kimball , A.P.: Metabolic Effects of Cyclic 9-β-D-Arabinofuranosyladenine 3',5'-Monophosphate in L1210 Cells , Cancer Res32:1791-1794, 1972 .
44.
Shipman, C. , JR.; Smith, S.H.; and Drach, J.C.: Selective Inhibition of Nuclear DNA Synthesis by 9-β-D-Arabinofuranosyl Adenine in Rat Cells Transformed by Rous Sarcoma Virus, Proc Nat Acad Sci U.S. 69: 1753-1757, 1972.
45.
Bennett, L.L. , JR. ; Shannon, W.M.; Al-Len , P.W.; and Arnett, G.: Studies on the Biochemical Basis for the Antiviral Activities of Some Nucleoside Analogs . Ann NY Acad Sci255:342-358, 1975.
46.
Graham, F.L. , and Whitmore, G.F.: The Effect of 1-β-D-Arabinofuranosylcytosine on Growth, Viability, and DNA Synthesis of Mouse L-Cells, Cancer Res30:2627-2635, 1970.
47.
Roller, B.A. ; Hirai, K.; and Defendi, V.: Effect of cAMP on Nucleoside Metabolism. II. Cell Cycle Dependence of Thymidine Transport , J Cell Physiol84:333-342, 1974.
48.
Grant, J.A. , and Sabina, L.R.: Inhibition of Vesicular Stomatitis Virus Replication by 9-β-D-Arabinofuranosyladenine, Antimicrob Agents Chemother2:201-205, 1972.
